Code | 3837E | ||||||||||
MA number | EU/1/18/1345/002 | ||||||||||
Product Form: | plv ifo 5x200 mg (liek.inj.skl.) | ||||||||||
MA Status: | Ex - Conditional centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | AstraZeneca AB, Sweden | ||||||||||
Therapeutic Class: | 19 - ANTIDOTA, DETOXICANTIA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 48 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 26.04.2019 |
Validity: | 30.04.2025 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 04.04.2024 |